(Q24244032)

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Clinical assessment and performance tasks in depression: a comparison of amitriptyline and trazodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A Comparison of Two Drug Treatments in Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Mianserin in the treatment of depressive illness: a comparison with amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A double-blind study of minaprine versus amitriptyline in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Clinical trial comparison of a sustained release form of amitriptyline with dothiepin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Amoxapine versus amitriptyline in endogenous depression. A double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A double-blind comparison of citalopram (Lu 10-171) and amitriptyline in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Dopaminergic agonist nomifensine compared with amitriptyline: a double- blind clinical trial in acute primary depressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Three Double-Blind Comparative Trials of Mianserine (ORG GB 94) and Amitriptyline in the Treatment of Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Tricyclic antidepressants in the treatment of depressions. A double-blind clinical comparison of clomipramine (Anafranil) and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A Double Blind Comparative Trial of Viloxazine and Amitriptyline in Patients Suffering from Endogenous Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A multinational, double-blind trial with a new antidepressant maprotiline (Ludiomil) and amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Once-daily treatment for mixed anxiety/depressive states: a comparison of slow release amitriptyline and fluphenazine with nortriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

The comparative antidepressant value of lofepramine and amitriptyline. Results of a controlled trial with comments on the scales used

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Comparative Trial of Nortriptyline and Amitriptyline in 100 Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A double-blind controlled trial of mianserin and amitriptyline in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Maprotiline — a Double-Blind Study of a New Tetracyclic Antidepressant in Severe Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Clinical Profile and Serum Concentration of Viloxazine as Compared to Amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A Comparative Clinical Trial of Mianserin (Norval®) and Amitriptyline in the Treatment of Depression in General Practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A Behavioral and Clinical Evaluation of Two Psychotropic Agents: Doxepin - Hydrochloride & Perphenazine - Amitriptyline Hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Amitriptyline and Trimipramine in Neurotic Depressed Outpatients: A Collaborative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Reduced REM latency predicts response to tricyclic medication in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Double-blind trial of sustained-release amitriptyline compared with viloxazine in moderate to severe depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Comparative effects of fluoxetine and amitriptyline on cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Double-blind clinical trial of the antidepressant action of amineptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A double-blind trial of maprotiline (Ludiomil) and amitriptyline in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Minaprine in depression. A controlled trial with amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A controlled comparison of fluoxetine and amitriptyline in depressed out-patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A comparison study of amitriptyline and nortriptyline with plasma levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Mianserin hydrochloride: a novel antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Open-label non-randomized versus double-blind randomized antidepressive treatment: what are the advantages of clinical decision over randomization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A Comparative Study of Antidepressants in the Treatment of Depressive States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Forty years of antidepressant drug trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Fortnightly review: drug treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

A Controlled Trial of Antidepressant Medication in Elderly In-Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A Double-Blind Clinical Trial of Mianserin Versus Amitriptyline: Differentiation by Adverse Symptomatology

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Experimental comparison between the effect of standardized trazodone-amitriptyline and placebo treatment in vitalized depressive patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A double-blind comparison of dothiepin and amitriptyline for the treatment of depression with anxiety

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Doxepin and amitriptyline-perphenazine in mixed anxious-depressed neurotic outpatients: a collaborative controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Clomipramine and amitriptyline in depressed outpatients. A controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Amitriptyline and nortriptyline response profiles in unipolar depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

An evaluation of trazodone in the treatment of depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A re-examination of the clinical effects of imipramine and amitriptyline in depressive illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Monoamine metabolites in cerebrospinal fluid of depressed patients during treatment with mianserin or amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Does lofepramine have fewer side effects than amitriptyline? Results of a comparative trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Diagnostic determinants of response to treatment with tricyclic antidepressants: a polydiagnostic approach

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Controlled evaluation of psychotropic drugs in a private psychiatric practice. Doxepin vs. amitriptyline (Elavil)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A Double - Blind Sequential Comparison of Doxepin with Amitriptyline in Depressed Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Biochemical hypotheses on antidepressant drugs: a guide for clinicians or a toy for pharmacologists?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A double-blind, multicentre study to assess the tolerability and efficacy of paroxetine compared with amitriptyline in the treatment of depressed patients in Australian general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

New diagnostic strategies in psychiatry by means of video-technique. I. The use of time-blind video analysis for the evaluation of antidepressant drug trials (author's transl)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Blood levels of mianserin and amitriptyline and clinical response in aged depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

[Comparison of the Hamilton Depression Rating Scale and the Self Rating Scale BS (v. Zerssen) within a double blind study on the antidepressant effects of trazodone verus amitriptyline (author's transl)]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Trazodone and amitriptyline in treatment of depressed inpatients. A double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Life events and response to antidepressants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Treatment of anxiety/depressive conditions in the elderly: a double-blind comparative study of Motival and amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Clinical activity and tolerability of trazodone, mianserin, and amitriptyline in elderly subjects with major depression: a controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A comparison of fluoxetine and amitriptyline in the treatment of major depression.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A double-blind multicentre study of paroxetine and amitriptyline in depressed outpatients. Italian Paroxetine Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Fluoxetine versus amitriptyline in the treatment of major depression with associated anxiety (anxious depression): a double-blind comparison.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

CONTROLLED COMPARISON OF AMITRIPTYLINE, IMIPRAMINE AND PLACEBO IN HOSPITALIZED DEPRESSED PATIENTS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Trazodone. A comparative clinical and predictive study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Paroxetine in the treatment of depression--a randomized comparison with amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Meta-analysis of early phase II studies with paroxetine in hospitalized depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A double-blind study to compare the effectiveness and tolerability of paroxetine and amitriptyline in depressed patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Paroxetine and amitriptyline in the treatment of depression in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Mianserin versus amitriptyline for depression: a double-blind 6-week trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Efficacy of tianeptine in anxious-depressed patients: results of a controlled multicenter trial versus amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Perspectives in clinical psychopharmacology of amitriptyline and fluvoxamine. A double-blind study in depressed inpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

The efficacy and safety of tianeptine in the treatment of depressive disorder: results of a controlled double-blind multicentre study vs. amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A double-blind non-crossover placebo-controlled study between group comparison of trazodone and amitriptyline on cardiovascular function in major depressive disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Clinical comparative evaluation of maprotiline, a new antidepressant drug. A multicentre study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A Double-Blind Trial with Amitriptyline and Lofepramine in the Treatment of Endogenous Depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Trazodone in depressed outpatients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Amoxapine versus amitriptyline combined with perphenazine in the treatment of psychotic depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

COMPARATIVE TRIAL OF NORTRIPTYLINE AND AMITRIPTYLINE

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A double-blind study of dothiepin hydrochloride (Prothiaden) and amitriptyline in out-patients with masked depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A Comparison of the Therapeutic and Cardiovascular Effects of a Single Nightly Dose of Prothiaden (Dothiepin, Dosulepin) and Lentizol (Sustained-Release Amitriptyline) in Depressed Elderly Patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Verbal Behaviour Changes with Depression Treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Antidepressant treatment of depression: a metaanalysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A general practitioner double-blind study of dothiepin hydrochloride (‘Prothiaden’) and amitriptyline in depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A single-blind comparative study of once daily dothiepin ("Prothiaden") and divided daily doses of amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Comparison of the efficacy of sustained-release amitriptyline with maprotiline in the treatment of depressive illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Amitriptyline in depressive states:a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Treatment of depression: a comparative study of E.C.T. and six drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A COMPARATIVE TRIAL OF IMIPRAMINE, AMITRIPTYLINE, ISOCARBOXAZID AND TRANYLCYPROMINE IN OUT-PATIENT DEPRESSIVE ILLNESS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

THE INFLUENCE OF CASE SELECTION AND DOSAGE IN AN ANTIDEPRESSANT DRUG TRIAL

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Double-blind comparison of nortriptyline and amitriptyline in depressive illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: serum levels and clinical response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

Imipramine and amitriptyline plasma concentrations and clinical response in major depression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A comparison of the antidepressant action of citalopram and amitriptyline

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021

A Multicentre Double Blind Trial of Fluoxetine versus Amitriptyline in the Treatment of Depressive Illness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004186.PUB2

7 January 2021